Prevention in liver disease

被引:6
作者
Arguedas, MR [1 ]
Fallon, MB [1 ]
机构
[1] Univ Alabama Birmingham, Ctr Liver, Dept Med, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA
关键词
education; prevention; screening; chronic liver disease; cirrhosis;
D O I
10.1097/00000441-200102000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prevention has become an important component of medical therapy for a variety of diseases. Preventive strategies in liver disease are relatively underdeveloped and have focused mainly on specific complications of chronic liver disease and vaccination for viral hepatitis. Although public health initiatives designed to prevent certain forms of liver disease are in place, they seem to be underutilized and their utility has not been evaluated. The development of a comprehensive approach using public health initiatives in conjunction with strategies by health care providers is important because of the potential for decreasing the human and health care costs associated with hepatic dysfunction. This article reviews the available literature regarding prevention for health care providers, includes a summary of ongoing public health initiatives, and suggests an approach to prevention in liver disease. It is intended to raise awareness and encourage implementation of preventive strategies in hepatology.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 39 条
[11]   Screening for hepatocellular carcinoma [J].
Collier, J ;
Sherman, M .
HEPATOLOGY, 1998, 27 (01) :273-278
[12]  
DAMICO G, 1995, HEPATOLOGY, V22, P332, DOI 10.1002/hep.1840220145
[13]  
Dumot JA, 1999, AM J GASTROENTEROL, V94, P1601, DOI 10.1111/j.1572-0241.1999.01150.x
[14]  
Durand M., 1997, Hepatology, V26, p219A
[15]  
EDWARDS CQ, 1993, NEW ENGL J MED, V328, P1616
[16]   THE SIGNIFICANCE OF ANTIBODY TO HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-B [J].
FONG, TL ;
DIBISCEGLIE, AM ;
WAGGONER, JG ;
BANKS, SM ;
HOOFNAGLE, JH .
HEPATOLOGY, 1991, 14 (01) :64-67
[17]  
Grace N D, 1997, Clin Liver Dis, V1, P59, DOI 10.1016/S1089-3261(05)70255-5
[18]   The hepatic venous pressure gradient: Has the time arrived for its application in clinical practice? [J].
Groszmann, RJ .
HEPATOLOGY, 1996, 24 (03) :739-741
[19]   Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease [J].
Keeffe, EB ;
Iwarson, S ;
McMahon, BJ ;
Lindsay, KL ;
Koff, RS ;
Manns, M ;
Baumgarten, R ;
Wiese, M ;
Fourneau, M ;
Safary, A ;
Clemens, R ;
Krause, DS .
HEPATOLOGY, 1998, 27 (03) :881-886
[20]   Etiology, screening, and treatment of hepatocellular carcinoma [J].
Khakoo, SI ;
Grellier, LFL ;
Soni, PN ;
Bhattacharya, S ;
Dusheiko, GM .
MEDICAL CLINICS OF NORTH AMERICA, 1996, 80 (05) :1121-+